Summary
Webinar Link
In the past five years, immunotherapy has transformed the approach to treating resectable lung cancer in both neoadjuvant and adjuvant settings. During this webinar, experts will explore the continued importance of radiation therapy in managing resectable lung cancer and highlight essential insights that thoracic surgeons need for daily practice.
Sponsored by AstraZeneca
Moderators
Nathaniel R. Evans III, MD
Thomas Jefferson University
Philadelphia, PA
John F. Lazar, MD
Ascension Saint Thomas
Nashville, TN
Presenters
Maria Werner-Wasik, MD
Thomas Jefferson University
Philadelphia, PA
Joshua Reuss, MD
MedStar Georgetown University Hospital
Washington, DC